Bank Of New York Mellon Corp I Bio, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $136,048 - $272,097	-591,516 Reduced 82.03%	129,616 $34,000
Q1 2022 May 11, 2022	SELL	$0.3 - $0.61 $5,441 - $11,063	-18,137 Reduced 2.45%	721,132 $309,000
Q4 2021 Feb 11, 2022	BUY	$0.55 - $1.04 $6,452 - $12,201	11,732 Added 1.61%	739,269 $406,000
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $123,699 - $177,380	116,698 Added 19.1%	727,537 $771,000
Q2 2021 Aug 11, 2021	BUY	$1.22 - $1.65 $121,698 - $164,592	99,753 Added 19.52%	610,839 $922,000
Q1 2021 May 13, 2021	BUY	$1.18 - $2.62 $98,415 - $218,515	83,403 Added 19.5%	511,086 $787,000
Q4 2020 Feb 09, 2021	BUY	$1.05 - $2.24 $246,451 - $525,763	234,716 Added 121.64%	427,683 $449,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $6.41 $59,683 - $225,042	35,108 Added 22.24%	192,967 $391,000
Q2 2020 Aug 12, 2020	BUY	$0.87 - $2.46 $96,820 - $273,768	111,288 Added 238.96%	157,859 $350,000
Q1 2020 May 06, 2020	BUY	$0.22 - $2.45 $10,245 - $114,098	46,571 New	46,571 $49,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.